Category: Top Story
-
UBS Predicts Silver Could Hit Record High as Investors Flock to Precious Metals
Silver has jumped to $42 an ounce, its highest level in 14 years, fueled by record-breaking gold prices and strong investment demand. Following this surge, UBS has upgraded its forecasts for the metal, projecting that silver could reach all-time highs within the next year. The bank now expects silver to trade at $44 an ounce…
-
Manchester United Shares Drop After Sixth Consecutive Annual Loss, Issues Soft Revenue Outlook
Manchester United (NYSE:MANU) on Wednesday revealed its sixth straight annual net loss, coupled with expectations of lower revenue in the current fiscal year, sending shares tumbling nearly 8% in premarket trading. The Premier League club reported a net loss of £33 million ($45 million) for the year ending June 30, an improvement from the £113.2…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Signal Flat Start Amid Fed Decision Anticipation
U.S. stock index futures were little changed early Wednesday, pointing to a muted opening as investors brace for the Federal Reserve’s policy announcement later in the day. The cautious mood mirrors Tuesday’s lackluster action, when major averages ended slightly lower after early gains faded. Market participants are largely in wait-and-see mode ahead of the Fed’s…
-
Deutsche Bank projects gold could reach $4,000 per ounce in 2026
Deutsche Bank analysts have increased their 2026 gold price forecast, citing strong recent gains in the metal and expectations for potential U.S. interest rate cuts, as well as ongoing questions over the Federal Reserve’s independence. In a client briefing, the team led by Michael Hsueh raised the average projected price for 2026 to $4,000 per…
-
WTO report: AI could lift global trade by nearly 40% by 2040
Artificial intelligence (AI) has the potential to expand the value of international trade in goods and services by almost 40% by 2040, according to the World Trade Report 2025, released Wednesday by the World Trade Organization (WTO). The report outlines scenarios in which global trade grows between 34% and 37%, depending on the pace of…
-
China Orders Local Firms to Halt Purchases of Nvidia AI Chips
China’s internet regulator has instructed major domestic technology companies to stop buying chips from Nvidia (NASDAQ:NVDA), the semiconductor leader favored in artificial intelligence, according to the Financial Times. Sources familiar with the matter told the FT that firms including ByteDance, owner of TikTok, and e-commerce giant Alibaba were directed by the Cyberspace Administration of China…
-
GSK and Eli Lilly Join $350 Billion U.S. Drug Investment Wave Amid Tariff Concerns
GSK (NYSE:GSK) and Eli Lilly (NYSE:LLY) announced new investments in U.S. manufacturing on Tuesday, joining a growing number of global pharmaceutical companies expanding domestic capacity as the Trump administration weighs tariffs on imported medicines. The Wall Street Journal first reported the trend, noting that more than a dozen drugmakers have committed over $350 billion in…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, Markets Cautious Ahead of Fed Rate Decision; General Mills Earnings on Deck
U.S. stock futures were largely flat Wednesday as investors awaited a key Federal Reserve interest rate decision. While the majority of market participants expect a cut in borrowing costs, uncertainty remains over its size and the Fed’s broader economic outlook. Meanwhile, U.K. inflation stayed steady, and packaged foods leader General Mills (NYSE: GIS) is set…
-
Take-Two Interactive Stock Reaches Record High at $250.68
Take-Two Interactive Software Inc. (NASDAQ:TTWO) hit a new all-time high of $250.68, marking a major milestone for the video game publisher. The company’s market capitalization now stands at $46.1 billion, with analyst price targets ranging from $150 to $285. Over the past year, the stock has surged 63.72%, reflecting investor confidence in Take-Two’s strategic initiatives…
-
Lantern Pharma Shares Soar as LP-184 Cancer Drug Hits Key Trial Goals
Shares of Lantern Pharma (NASDAQ:LTRN) jumped 10% following the announcement that its cancer therapy LP-184 met all primary endpoints in a Phase 1a trial, showing a favorable safety profile and promising antitumor activity in patients with advanced solid tumors. The AI-driven oncology company said the open-label, multicenter study evaluated LP-184 in 63 patients with advanced,…